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Cyclization of the lactam carbonyl on the indole ring in 
tryptophanol-derived oxazolopiperidone lactams 2 and 6, under the 
classical POCl3-promoted Bischler−Napieralski conditions  and  
under   neutral   conditions  via  the  corresponding   thiolactam,   is 
studied. Whereas tricyclic lactam 2 only leads to products 
coming from an α-amidoalkylation process, bicyclic lactam 6 
undergoes cyclization on the lactam carbonyl, leading to the 
expected indolo[2,3-a]quinolizidine derivatives. 
Introduction 
Tryptophanol-derived oxazolopiperidone lactams have proven to 
be versatile chiral building blocks for the enantioselective synthesis 
of indole alkaloids.[1] These lactams are easily accessible in 
enantiopure form in a single synthetic step by a stereoselective 
cyclocondensation reaction between (S)-tryptophanol and an 
appropriate δ-oxo acid derivative.[2] Tryptophanol not only 
constitutes the source of chirality but can also be used in 
subsequent steps to assemble complex polycyclic targets by regio- 
and stereocontrolled cyclization reactions on the indole ring.  
Taking advantage of the functionalization present i the 
oxazolopiperidone lactam, an electrophilic cyclization on the 
indole 2-position can involve either the hemiaminal ether carbon 
via an N-acyliminium cation (via a)[1a-d,2] or the lactam carbonyl 
via a Bischler−Napieralski-type reaction (via b),[1e,3] leading to 
regioisomeric indolo[2,3-a]quinolizidines (when R1 ≠ H). 
Additionally, by choosing the appropriate reaction conditions, the 
intramolecular α-amidoalkylation allows the stereocontrolled 
generation of C-12b epimeric derivatives. On the other hand, a 
Lewis acid/Et3SiH-promoted cyclization on the indole 3-position 
from Na-tosyl derivatives provides straightforward access to the 
spiro[indole-3,1’-indolizidine] framework[4] present in a large 
number of alkaloids (via c). These complementary types of 
cyclization are shown in Scheme 1.   
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Scheme 1. Regio- and stereocontrolled cyclizations from (S)-tryptophanol-
derived oxazolopiperidone lactams.  
 
Although there are many examples of acid-promoted 
intramolecular α-amidoalkylation reactions from (S)-tryptophanol-
derived oxazolopiperidone lactams, cyclizations involving the 
lactam carbonyl have been little explored. In fact, our initial 
attempts to perform a Bischler−Napieralski cyclization under the 
classical conditions (POCl3, then NaBH4) were unsuccessful
[1e,5] 
due to the tendency of these lactams to undergo acid-promoted 
intramolecular α-amidoalkylation reactions. However, the desired 
cyclization on the lactam carbonyl can be satisfactorily performed 
under non-acidic conditions by a modified Bischler−Napieralski 
procedure via a (benzylthio)iminium intermediate.[1e] In the only 
example reported to date of a successful POCl3-promoted 
Bischler−Napieralski cyclization from a tryptophanol-derived 
oxazolopiperidone lactam,[3] the hemiaminal ether carbon 
incorporates an additional substituent, which, for steric reasons, 
seems to hamper the intramolecular α-amidoalkylation reaction.  
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Scheme 2. Studies on the synthesis of normalindine. Cyclization under Bischler−Napieralski conditions. 
 
Results and Discussion 
With these precedents in mind, we decided to explore if the 
methodology could be applied to the synthesis of malindine 
alkaloids, for instance normalindine,[6] which are characterized by 
the presence of a partially reduced 1-methyl-2,7-naphthyridine 
moiety (Scheme 2). The synthesis would involve as the key steps a 
cyclocondensation reaction between (S)-tryptophanol and pyridine 
δ-keto ester 1, a Bischler−Napieralski cyclization from the 
resulting tricyclic lactam, and finally, the reductive opening of the 
oxazolidine ring with subsequent removal of the hydroxymethyl  
appendage.[7] The quaternary carbon 10b on the oxazolidine ring 
would hamper the α-amidoalkylation process in favor of the 
Bischler−Napieralski cyclization. 
As foreseen, the cyclocondensation reaction took place in 
acceptable yield (65%) and excellent stereoselectivity to give the 
trans 3-H/10b-Me 2,7-naphthyridine lactam 2.[8] However, rather 
unexpectedly, treatment of this lactam under classic l 
Bischler−Napieralski conditions (POCl3, then NaBH4) resulted in 
an α-amidoalkylation process, leading to hexacycle 3 (42% yield) 
and pentacycle 4 (21% yield). No products coming from the 
cyclization of the lactam carbonyl on the indole ring were detected.  
The formation of 3 can be rationalized by considering a rapid 
generation of an N-acyliminium cation[9] and its cyclization on the 
indole ring, a subsequent interaction of the hydroxymethyl 
substituent with the chloroiminium intermediate generated from the 
lactam carbonyl, and a final reduction by NaBH4 of the resulting 
oxazolinium salt.[10] A further reduction, with opening of the 
oxazolidine ring, would lead to 4.  
The cis 1-Me/3-H relative stereochemistry for the tetrahydro−β-
carboline moiety, established by NOE experiments, probably 
results from an acid-promoted epimerization[11] of the quaternary 
stereocenter initially formed in the cyclization,[12] driven by the 
generation of a cis oxazolinium intermediate, A. A final 
stereoelectronically controlled[13] axial attack of the hydride installs 
the all-cis relative configuration of 3.  
To avoid the undesirable acid-promoted α-amidoalkylation 
reaction, we decided to perform a Bischler−Napieralski-type 
cyclization under neutral conditions[1e] from the thiolactam derived 
from 2. Surprisingly, treatment of lactam 2 with Lawesson’s 
reagent led in excellent yield (81%) to the hexacycli  
thioderivative 5 instead of the expected thiolactam (Scheme 3). 
The formation of 5 can be accounted for by considering that, once 
the thiolactam was formed, the generation of the N-thioacyl 
iminium ion B was facilitated by the lower electronegativity of the 
sulfur atom. Cyclization on the indole ring would afford 
pentacyclic intermediate C. A subsequent cyclization via the O-
alkyl phenylphosphonodithioic acid intermediate D[14] would lead 
to 5.  
The above results indicate that an acidic environment is not the 
only factor to favor the competitive α-amidoalkylation reaction. 
Most probably, due to the presence of the fused π- eficient 
pyridine, the benzylic character of the N-acyl (or thioacyl) iminium 
species generated by the opening of the oxazolidine ring also plays 




















































Scheme 3. Reaction of lactam 2 with Lawesson’s reagent. 
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To gain further insight into the factors governing the 
regioselectivity of the cyclization on the carbonyl group of 
tryptophanol-derived oxazolopiperidone lactams, we decided to 
study the Bischler−Napieralski cyclization from a model lactam 6, 
which lacks the pyridine ring present in 2. This lactam was 
prepared by cyclocondensation between (S)-tryptophanol and 5-
oxohexanoic acid. Under the usual reaction conditions (toluene, 
reflux), a mixture of 6 and its 8a-epimer (80% yield, 87:13 ratio) 
was obtained[15] (Scheme 4). A more convenient experimental 
procedure involved the use of microwaves:[16] irradiation of an 
equimolecular mixture of the starting materials for 10 min at 110 
ºC provided a 92:8 diastereoisomeric mixture of 6 and its 8a-
epimer in 77% yield, with only traces of the cyclized product 9 
(Scheme 5) being detected. 
 
Scheme 4. Cyclizations on the lactam carbonyl from lactams 6. 
As expected, cyclization on the lactam carbonyl took place 
satisfactorily from lactams 6, not only under neutral conditions via 
a thiolactam but also under the classical POCl3-promoted 
Bischler−Napieralski conditions. Thus, the epimeric mixture of 6 
was converted to the corresponding thiolactams (54%), which were 
treated with benzyl bromide and then NaBH4, to regio- and 
stereoselectively give (51%) a single pentacyclic 
indoloquinolizidine derivative 7. Similarly, treatment of the 
epimeric mixture of 6 with POCl3 and then NaBH4 
stereoselectively led to a 3:2 mixture of pentacycle 7 and 
indoloquinolizidine 8 in 52% overall yield.[17] The former was 
quantitatively converted to 8 by additional treatment with 
NaBH4.
[18] 
The all-cis stereochemistry of 7, established by NOE 
experiments (4-Me/6-H, 4-Me/12b-H, and 6-H/12b-H), deserves 
some comment as the sterocenters bearing the methyl substituent in 
the major starting lactam 6 and in the cyclized product 7 have the 
opposite relative configuration. This indicates that during the above 
cyclization an equilibration has occurred via an open oxazolidine 
intermediate, ultimately leading to the less strained cis 4-Me/6-H 
iminium salt E (Figure 1), which undergoes a final 
stereoelectronically controlled[13] axial attack of the hydride. 
Finally, also worthy of comment is the inversion of the 
configuration during the reductive opening of the oxazolidine ring 
to give 8, once again involving a stereoelectronically contrlled 
attack of the hydride on the less hindered face of the intermediate 
iminium species F.  
 
Figure 1. Stereocontrolled reduction of iminium ionntermediates. 
The above successful Bischler−Napieralski-type cyclizations 
make evident that the intramolecular α-amidoalkylation process is 
slowed down by the presence of the additional substit ent at the 2-
position of the oxazolidine ring. In fact, lactams 6 were recovered 
unchanged (only trace amounts of the cyclized product 9 were 
detected) after treatment with HCl (0.6 M in EtOH, rt, 24 h), 
whereas these reaction conditions promote a clean and highly 
stereoselective α-amidoalkylation (95% yield) when applied to the 
corresponding lactams lacking the angular methyl substituent.[5] 
Under more drastic conditions (1.25 M HCl in EtOH, 70 ºC, 72 h), 
cyclization of 6 took place in good yield (70%) but with a low 
stereoselectivity to give a nearly 1:1 mixture of trans and cis 
indoloquinolizidines 10 and 12b-epi-9, probably because the strong 
acidity causes the epimerization at C-12b of the indolo[2,3-
a]quinolizidine system[12] (Scheme 5). From the synthetic 
standpoint, the best results were obtained using a 0.9 M solution of 
TFA in CH2Cl2 (rt, 20 h), since a 4:1 stereoisomeric mixture of 
indoloquinolizidines 9 and 12b-epi-9 was obtained in 86% yield. 
The absolute configuration of the cyclized products 9 and 12b-epi-
9 was unambiguously determined by X-ray crystallographic 
analysis.[19] 
 
Scheme 5. α-Amidoalkylation reaction from lactams 6.
The stereoselective formation of 9 leading to a trans 6-H/12b-
Me stereochemistry can be rationalized by analyzing the two 
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possible reactive chair-like conformations (X and Y; R= Me) of the 
intermediate N-acyliminium cation.[9] Cyclization takes place faster 
from conformation X, which avoids the severe A(1,3) strain between 
the hydroxymethyl substituent and the lactam carbonyl group in the 
transition state.[20] The lower stereoselectivity in the cyclization of 
6 compared with that of the corresponding demethyl lactam[2a,5] can 
be explained by the stronger A(1,3) CH2OH/R strain present in the 
conformation X when R= Me than when R= H. 
Conclusions 
Although  under the classical POCl3-promoted 
Bischler−Napieralski reaction conditions tryptophanol-derived 
oxazolopiperidone lactams unsubstituted at the hemiaminal ether 
carbon (i.e. generated from aldehyde-esters) undergo an 
intramolecular α-amidoalkylation reaction instead of the expected 
cyclization on the lactam carbonyl, lactams substituted at this 
position (e.g. 6, derived from a ketone-ester) successfully undergo 
a regioselective Bischler−Napieralski cyclization onthe lactam 
carbonyl, avoiding the competitive α-amidoalkylation process.  
 The unexpected behavior of tricyclic lactam 2, which 
exclusively leads to products coming from an α-amidoalkylation 
process, is a consequence of the presence of the fusedπ-deficient 
pyridine ring that originates a reactive benzylic-type N-acyl (or 
thioacyl) iminium ion. 
Experimental Section 
General: Flash chromatography was carried out on SiO2 (silica gel 
60, SDS, 35-70 µm or using Biotage® SNAP cartridges, 50 µm). 
Optical rotations were measured on Perkin-Elmer 241 polarimeter. 
High resolution mass spectra (HMRS; LC/MSD TOF Agilent 
Technologies) were performed by Centres Científics i Tecnològics 
de la Universitat de Barcelona. Microanalyses (Carlo Erba 1106 
analyzer) were performed by Centre d’Investigació i 
Desenvolupament (CSIC), Barcelona. Only noteworthy IR 
absorptions (cm-1; Nicolet Avantar 320 FT-IR) are listed. NMR 




oxazolo[2,3-a][2,7]naphthyridine (2):  (S)-tryptophanol (228 mg, 
1.2 mmol) and isobutyric acid (132 mg, 1.5 mmol) were added to a 
solution of compound 1[21] (200 mg, 1 mmol) in toluene (16 mL). 
The mixture was heated at reflux for 19 h with azeotropic 
elimination of water by a Dean-Stark system. The resulting mixture 
was cooled and concentrated under reduced pressure. The residue 
was dissolved in CH2Cl2 and the solution was washed twice with 
saturated aqueous NaHCO3 solution. The organic phase was dried, 
filtered, and concentrated. Flash chromatography (2:8 
hexane/EtOAc) gave lactams 2 and 10b-epi-2 as a 96:4 mixture 
(218 mg, 65%).  
 
Data for 2 (from the mixture): 1H NMR (400 MHz, CDCl3, COSY, 
HSQC, 25 ºC): δ = 1.52 (s, 3H, CH3), 3.16 (dd, J = 14.0, 10.0 Hz, 
1H, CH2),  3.50 (dd, J = 14.0, 3.6 Hz, 1H, CH2), 3.58 (d, J = 18.4 
Hz, 1H, H-6), 3.73 (d, J = 18.4 Hz, 1H, H-6), 3.93 (dd, J = 8.6, 6.4 
Hz, 1H, H-2), 4.09 (dd, J = 8.6, 4.8 Hz, 1H, H-2), 4.60 (m, 1H, H-
3), 7.11 (d, J = 2.0 Hz, 1H, H-2’), 7.15 (masked d, 1H, H-7), 7.16 
(td, J = 8.0, 1.2 Hz, 1H, H-6’), 7.21 (td, J =  7.2, 1.2 Hz, 1H, H-5’), 
7.37 (d, J = 8.0 Hz, 1H, H-7’), 7.80 (d, J = 7.2 Hz, 1H, H-4’), 8.32 
(br. s, 1H, NH), 8.52 (br. s, 1H, H-8), 8.69 (br. s, 1H, H-10) ppm. 
13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 28.2 (CH3), 28.5 (CH2), 
37.6 (C-6), 56.5 (C-3), 69.1 (C-2), 92.8 (C-10b), 111.2 (C-7’), 
111.6 (C-3a’), 119.1 (C-4’), 119.8 (C-6’), 121.9 (C-7), 122.3 (C-
5’), 122.5 (C-2’), 127.6 (C-7a’), 136.2 (C-10a), 139.1 (C-6a), 144.7 
(C-10), 149.4 (C-8), 165.6 (CO) ppm. IR (NaCl): υ = 1411, 1651, 




Data for 10b-epi-2 (from an enriched mixture): 1H NMR (400 
MHz, CDCl3, 25 ºC): δ = 1.54 (s, 3H, CH3), 2.63 (dd, J = 14.0, 
10.0 Hz, 1H, CH2), 3.61 (dd, J = 14.0, 2.8 Hz, 1H, CH2), 3.62 (d, J 
= 19.2 Hz, 1H, H-6), 3.72 (d, J = 19.2 Hz, 1H, H-6), 4.20 (dd, J = 
9.6, 2.0 Hz, 1H, H-2), 4.24 (dd, J = 9.6, 1.2 Hz, 1H, H-2), 4.49 
(dddd, J = 10.0, 5.2, 2.8, 2.8 Hz, 1H, H-3), 6.97 (d, J = 2.0 Hz, 1H, 
H-2’), 7.10-7.22 (masked m, 3H, H-7, H-5’, H-6’), 7.29 (br. d, J = 
8.0 Hz, 1H, H-7’), 7.75 (d, J = 7.6 Hz, 1H, H-4’), 8.16 (br. s, 1H, 
NH), 8.52 (masked d, 1H, H-8), 8.65 (br. s, 1H, H-10) ppm. 
NOESY 1D: positive NOE effect: 3-H/10b-Me. 
 
Treatment of 2 under Bischler−Napieralski conditions: POCl3 
(373 µL, 4.08 mmol) was added to a solution of lactams 2 and epi-
2 (100 mg, 0.3 mmol) in toluene (3.8 mL), and the mixture has 
heated at 100 °C for 1.5 h. After cooling, the solvent was removed 
and the resulting brown residue was dissolved in anhydrous MeOH 
(6 mL). Then, NaBH4 (136 mg, 3.6 mmol) was slowly added to the 
solution at 0 °C, and the mixture was allowed to reach room 
temperature for 2 h and refluxed for 2.5 h. The mixture was cooled 
at 0 °C and quenched by addition of saturated aqueous NaHCO3. 
The solvent was evaporated, and the resulting residu  was 
dissolved in CH2Cl2. The organic phase was washed with brine, 
dried, and concentrated. Flash chromatography of the residue (95:5 
CH2Cl2/MeOH) afforded hexacycle 3 (40 mg, 42%) and pentacycle 
4 (20 mg, 21%). 
 
Data for 3: Yellow oil. [α]22D = –101.5 (c = 0.9, CHCl3).
 1H NMR 
(400 MHz, CDCl3, COSY, HSQC, 25 ºC): δ = 2.02 (s, 3H, CH3), 
2.90 (ddd, J = 15.2, 9.2, 0.8 Hz, 1H, H-5), 2.97 (dd, J = 16.5, 7.6 
Hz, 1H, H-9), 3.04 (dd, J = 16.5, 9.2 Hz, 1H, H-9), 3.13 (dd, J = 
15.2, 3.2 Hz, 1H, H-5), 4.02 (d, J = 6.8 Hz, 1H, CH2O), 4.22 (m, 
1H, H-8), 4.29 (dd, J = 6.8, 4.8 Hz, 1H, CH2O), 4.57 (dd, J = 9.2, 
3.2 Hz, 1H, H-6), 7.10 (masked d, 1H, H-4), 7.10 (masked td, 1H, 
H-11), 7.15 (td, J = 7.2, 1.2 Hz, 1H, H-12), 7.30 (d, J = 8.0 Hz, 1H, 
H-10), 7.47 (d, J = 7.2 Hz, 1H, H-13), 8.37 (d, J = 4.8 Hz, 1H, H-
3), 8.95 (br. s, 1H, NH), 9.19 (s, 1H, H-1) ppm. NOESY 1D: 
positive NOE effect: 1-Me/3-H. 13C NMR (100.6 MHz, CDCl3, 25 
ºC): δ = 21.9 (C-9), 31.7 (CH3), 36.3 (C-5), 50.9 (C-8), 56.9 (C-
14b), 72.3 (CH2O), 83.1 (C-6), 104.7 (9a), 111.2 (C-13), 118.2 (C-
10), 119.7 (C-11), 122.2 (C-12), 125.4 (C-4), 127.2 (C-9b), 135.8 
(C-14a), 135.9 (C-13a), 136.5 (C-14c), 142.3 (C-1), 147.4 (C-3), 
147.6 (C-4a) ppm. IR (NaCl): υ = 2942, 3182 cm-1. HRMS calcd. 
for C20H20N3O [M + H]
+: 318.1601; found: 318.1601.  
 
Data for 4: Yellow oil. [α]22D = –1.5 (c = 1.0, MeOH). 
1H NMR 
(400 MHz, CDCl3, COSY, HSQC, 25 ºC): δ = 2.03 (s, 3H, CH3), 
2.63 (d, J = 8.8 Hz, 1H, H-9), 2.64 (masked, 1H, H-9), 2.67-2.69 
(m, 1H, H-5), 2.72 (dd, J = 9.6, 3.2 Hz, 1H, H-6), 3.00-3.14 (m, 2H, 
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H-5, H-6), 3.79 (dd, J = 10.8, 5.2 Hz, 1H, CH2OH), 3.87 (t, J = 
10.8 Hz, 1H, CH2OH), 4.06 (m, 1H, H-8), 7.06 (masked d, J = 4.8 
Hz, 1H, H-4), 7.09 (td, J = 7.2, 1.2 Hz, 1H, H-11), 7.14 (td, J = 7.2, 
1.2 Hz, 1H, H-12), 7.29 (d, J = 7.2 Hz, 1H, H-10), 7.45 (d, J = 7.2 
Hz, 1H, H-13), 8.36 (d, J = 5.2 Hz, 2H, H-3), 9.08 (s, 1H, H-1) 
ppm. NOESY 1D: positive NOE effect: 1-Me/3-H. 13C NMR 
(100.6 MHz, CDCl3, 25 ºC): δ = 19.6 (C-9), 29.6 (C-5), 29.9 (CH3), 
36.2 (C-6), 53.9 (C-8), 58.7 (C-14b), 61.4 (CH2O), 105.9 (C-9a), 
111.2 (C-13), 118.2 (C-10), 119.7 (C-11), 122.1 (C-12), 124.2 (C-
4), 127.1 (C-9b), 136.2 (C-13a), 136.8 (C-14a), 137.  (C-14c), 
144.5 (C-4a), 147.3 (C-3), 147.8 (C-1) ppm. IR (NaCl): υ = 1600, 
3273 cm-1. HRMS calcd. for C20H22N3O [M + H]
+: 320.1757; 
found: 320.1763.  
 
Treatment of 2 with Lawesson’s Reagent: Lawesson’s reagent 
(210 mg, 0.52 mmol) was added to a solution of lactams 2 and 10b-
epi-2 (150 mg, 0.45 mmol) in DME (2.7 mL).The resulting mixture 
was heated at reflux for 12 h, cooled, and concentrated. The 
resulting dark orange residue was dissolved in CH2Cl2, and the 
organic solution was washed twice with saturated aqueous 
NaHCO3 solution. The organic layer was dried, filtered, and 
concentrated. Flash chromatography (1:4 hexane/EtOAc) afforded 
5 (120 mg, 81%) as a yellow oil: [α]22D = –1.8 (c = 0.5, CHCl3). 
1H 
NMR (400 MHz, CDCl3, COSY, HSQC, 25 ºC): δ = 1.69 (s, 3H, 
CH3), 2.91 (dd, J = 13.5, 10.5 Hz, 1H, CH2S), 3.08 (m, 2H, H-9), 
3.45 (dd, J = 13.5, 6.0 Hz, 1H, CH2S), 4.39 (m, 1H, H-8), 5.46 (s, 
1H, H-5), 6.67 (d, J = 4.8 Hz, 1H, H-4), 7.09 (m, 2H, H-11 and H-
12), 7.41 (d, J = 7.6 Hz, 1H, H-13), 7.49 (d, J = 7.6 Hz, 1H, H-10), 
8.08 (d, J = 4.4 Hz, 1H, H-3), 8.98 (s, 1H, H-1), 11.82 (br. s, 1H, 
NH) ppm. NOESY 1D: positive NOE effect: 8-H/14b-Me. 13C 
NMR (75.4 MHz, CDCl3, 25 ºC): δ = 23.6 (CH3), 27.3 (C-9), 33.7 
(CH2S), 59.9 (C-14b), 60.3 (C-8), 90.6 (C-5), 106.9 (9a), 111.9 (C-
13), 115.8 (C-4), 117.8 (C-10), 119.2 (C-11), 121.9 (C-12), 125.1 
(C-9b), 126.0 (C-14a), 134.5 (C-13a), 137.6 (C-14c), 142.5 (C-1), 
143.4 (C-4a), 146.4 (C-3), 153.5 (C-6) ppm. IR (NaCl): υ = 1467, 
1572, 2926 cm-1. HRMS calcd. for C20H18N3S [M+ H]
+: 332.1216; 
found: 332.1214.  
 
(3S,8aR)-3-(3-Indolylmethyl)-8a-methyl-5-oxo-2,3,6,7,8,8a-
hexahydro-5H-oxazolo[3,2-a]pyridine (6):  
Method A: (S)-Tryptophanol (292 mg, 1.5 mmol) was added to a 
solution of 5-oxohexanoic acid (200 mg, 1.5 mmol) in toluene (23 
mL). The mixture was heated at reflux for 23 h with azeotropic 
elimination of water by a Dean-Stark apparatus. Themixture was 
cooled and concentrated. Flash chromatography of the residue (2:8 
hexane/EtOAc) afforded a mixture of lactams 6 and 8a-epi-6 (340 
mg, 80%; 87:13 by GC-MS) as a light yellow foam and 50 mg of 9 
(11%). 
Method B: (S)-Tryptophanol (70 mg, 0.38 mmol) and 5-
oxohexanoic acid (50 mg, 0.38 mmol) in toluene (3 mL) were 
mixed in a capped 10 mL microwave vessel. The mixture was 
heated at 110 °C (average effective ramp time = 1 min). The power 
was set at 100 W and the pressure was set at 15 bar for 10 min. The 
solvent was evaporated, and the residue was dissolved in CH2Cl2. 
The organic phase was washed with 1 N aqueous HCl and 
saturated aqueous NaHCO3 solutions, dried, filtered, and 
evaporated to afford a mixture of 6 and 8a-epi-6 (83 mg, 77%; 92:8 
calculated by 1H NMR). 
 
Data for 6 (from the mixture): 1H NMR (400 MHz, CDCl3, COSY, 
HSQC, 25 ºC): δ = 1.31 (s, 3H, CH3), 1.56 (td, J = 13.0, 4.0 Hz, 1H, 
H-8), 1.69-1.83 (m, 1H, H-7), 1.84-1.98 (m, 1H, H-7), 2.06 (dt, J = 
13.0, 3.6 Hz, 1H, H-8), 2.38 (ddd, J = 18.4, 10.0, 8.0 Hz, 1H, H-6), 
2.54 (dd, J = 18.4, 8.0 Hz, 1H, H-6), 2.91 (dd, J = 14.0, 10.4 Hz, 
1H, CH2), 3.55 (ddd, J = 14.0, 3.2, 0.8 Hz, 1H, CH2), 3.85 (dd, J = 
8.5, 7.6 Hz, 1H, H-2), 3.98 (dd, J = 8.5, 7.5 Hz, 1H, H-2), 4.58 (m, 
1H, H-3), 6.98 (d, J = 1.6 Hz, 1H, H-2’), 7.10 (td, J = 8.0, 1.2 Hz, 
1H, H-5’), 7.17 (td, J = 7.6, 1.2 Hz, 1H, H-6’), 7.33 (d, J = 7.6 Hz, 
1H, H-7’), 7.77 (d, J = 8.0 Hz, 1H, H-4’), 8.61 (br. s, 1H, NH) ppm. 
13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 16.9 (C-7), 23.7 (CH3), 
29.4 (CH2), 30.4 (C-6), 34.9 (C-8), 55.9 (C-3), 68.0 (C-2), 93.2 (C-
8a), 111.1 (C-7’), 111.5 (C-3’), 119.1 (C-4’), 119.3 (C-5’), 121.9 
(C-6’), 122.2 (C-2’), 127.5 (C-3a’), 136.2 (C-7a’), 169.2 (CO) ppm. 
IR (NaCl): υ = 1626, 3284 cm-1. HRMS calcd. for C17H21N2O2 [M 
+ H]+: 285.1598; found: 285.1596.  
 
Data for 8a-epi-6 (from a enriched mixture): 1H NMR (400 MHz, 
CDCl3, 25 ºC): δ = 1.34 (s, 3H, CH3), 1.64 (dd, J = 12.5, 6.8 Hz, 
1H, H-8), 1.79-1.98 (m, 2H, H-7), 2.11 (ddd, J = 12.5, 5.6, 2.8 Hz, 
1H, H-8), 2.43-2.50 (m, 2H, H-6), 2.67 (dd, J = 13.8, 10.0 Hz, 1H, 
CH2), 3.78 (ddd, J = 13.8, 2.9, 0.8 Hz, 1H, CH2),  3.95 (br. s, 1H, 
H-2), 3.96 (br. s, 1H, H-2), 4.35 (m, 1H, H-3), 7.01 (d, J = 2.4 Hz, 
1H, H-2’), 7.12 (td, J = 8.0, 1.2 Hz, 1H, H-5’), 7.18 (td, J = 8.0, 1.2 
Hz, 1H, H-6’), 7.34 (d, J = 7.6 Hz, 1H, H-7’), 7.81 (d, J = 8.0 Hz, 
1H, H-4’), 8.29 (br. s, 1H, NH) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 ºC): δ = 16.7 (C-7), 22.9 (CH3), 26.6 (CH2), 29.6 (C-6), 
34.6 (C-8), 56.3 (C-3), 67.3 (C-2), 93.2 (C-8a), 111.0 (C-7’), 112.5 
(C-3’), 119.3 (C-4’), 119.5 (C-5’), 122.1 (C-6’), 122.3 (C-2’), 
127.7 (C-3a’), 136.2 (C-7a’), 168.4 (CO) ppm. IR (NaCl): υ = 1626, 
3284 cm-1. HRMS calcd. for C17H21N2O2 [M + H]
 +: 285.1598; 
found: 285.1596.  
 
(4S,6S,12bS)-4,6-(Epoxymethano)-4-methyl-1,2,3,4,6,7,12,12b-
octahydroindolo[2,3-a]quinolizine (7): Lawesson’s reagent (384 
mg, 0.95 mmol) was added to a solution of lactams 6 and 8a-epi-6 
(300 mg, 1.1 mmol) in DME (10 mL). The resulting mixture was 
heated at reflux for 4.5 h, cooled, and concentrated to give a dark 
brown residue, which was dissolved in EtOAc. The soluti n was 
washed twice with saturated aqueous NaHCO3. The organic layer 
was dried, filtered, and concentrated to give 400 mg of a yellow 
foam. Flash chromatography (hexane to 8:2 hexane/EtOAc) gave a 
mixture of thiolactams (179 mg, 54%; 9:1 by GC-MS) as a white 
solid: 1H NMR (400 MHz, CDCl3, COSY, HSQC, 25 ºC, major 
epimer): δ = 1.42 (s, 3H, CH3), 1.67 (dd, J = 12.5, 5.8 Hz, 1H, H-8), 
1.70-1.82 (m, 1H, H-7), 1.84-1.95 (m, 1H, H-7), 2.03-2.14 (m, 1H, 
H-8), 2.94 (dd, J = 13.7, 10.7 Hz, 1H, H-6),  3.07-3.13 (m, 2H, H-6, 
CH2), 3.57-4.18 (m, 3H, CH2, H-2), 4.92-5.19 (m, 1H, H-3), 7.05 
(d, J = 1.9 Hz, 1H, H-2’), 7.12-7.18 (m, 1H, H-5’), 7.19-7.25 (m, 
1H, H-6’), 7.35 (d, J = 7.8 Hz, 1H, H-7’), 7.99 (d, J = 7.8 Hz, 1H, 
H-4’), 8.24 (br. s, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 
ºC): δ = 16.8 (C-7), 22.9 (CH3), 27.7 (CH2), 34.1 (C-6), 39.6 (C-8), 
61.1 (C-3), 67.1 (C-2), 94.6 (C-8a), 111.0 (C-7’), 111.3 (C-3’), 
119.5 (C-4’), 119.6 (C-5’), 122.1 (C-6’), 122.3 (C-2’), 127.4 (C-
3a’), 136.1 (C-7a’), 197.0 (CO) ppm. BnBr (134 µL, 1.13 mmol) 
was added to a solution, kept in the dark, of the above thiolactams 
(170 mg, 0.57 mmol) in CH3CN (4.5 mL), and the resulting 
mixture was heated at 60 °C for 48 h. The solvent was removed 
under reduced pressure, and the dark yellow residue was dissolved 
in MeOH (15 mL). Then, NaBH4 (65 mg, 1.71 mmol) was added at 
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–78 °C, and the mixture was allowed to reach room te perature 
and stirred for 4.5 h. Acetone (0.5 mL) was added, and the solvent 
was evaporated. The resulting residue was dissolved in CH2Cl2, 
and the solution was washed with brine. The organic phase was 
dried and concentrated to give a yellow oil (300 mg), which was 
chromatographed (7:3 hexane/EtOAc) to afford 7 (78 mg, 51%) as 
a yellow oil: [α]22D = –109.1 (c = 0.7, CHCl3). 
1H NMR (400 MHz, 
CDCl3, COSY, HSQC, 25 ºC): δ = 1.20 (s, 3H, CH3), 1.46 (m, 1H, 
H-2), 1.62 (m, 2H, H-1, H-3), 1.93 (m, 2H, H-1, H-3), 2.05 (m, 1H, 
H-2), 2.58 (ddd, J = 14.4, 10.0, 2.4 Hz, 1H, H-7), 3.01 (ddd, J = 
14.4, 4.4, 1.6 Hz, 1H, H-7), 3.32 (m, 1H, H-6), 3.72 (t, J = 7.5 Hz, 
1H, CH2O), 3.84 (br. dd, J = 10.8, 1.6 Hz, 1H, H-12b), 4.23 (t, J = 
7.5 Hz, 1H, CH2O), 7.09 (dd, J = 7.2, 1.2 Hz, 1H, H-9), 7.14 (dd, J 
= 7.2, 1.2 Hz, 1H, H-10), 7.31 (d, J = 7.2 Hz, 1H, H-11), 7.47 (d, J 
= 7.2 Hz, 1H, H-8), 7.88 (br. s, 1H, NH) ppm. NOESY 1D: 
positive NOE effects: 4-Me/6-H, 4-Me/12b-H, and 6-H/12b-H. 13C 
NMR (100.6 MHz, CDCl3, 25 ºC): δ = 13.9 (CH3), 21.9 (C-2), 26.2 
(C-7), 30.8 (C-1), 36.6 (C-3), 51.3 (C-12b), 52.5 (C-6), 70.3 
(CH2O), 91.5 (C-4), 107.7 (C-7a), 110.7 (C-11), 118.0 (C-8), 119.4 
(C-9), 121.4 (C-10), 127.2 (C-7b), 135.5 (C-12a), 136.5 (C-11a) 
ppm. IR (NaCl): υ = 3267 cm-1. HRMS calcd. for C17H21N2O [M + 
H]+: 269.1648; found: 269.1644.  
 
Treatment of 6 under Bischler−Napieralski conditions: POCl3 
(500 µL, 5.5 mmol) was added to a solution of lactams 6 and epi-6 
(100 mg, 0.35 mmol) in toluene (5 mL), and the mixture was 
heated at 100 °C for 2 h. After cooling, the solvent was removed, 
and the brown residue was dissolved in anhydrous MeOH (7 mL). 
Then, NaBH4 (excess, until basic pH) was slowly added to the 
solution at 0 °C, and the mixture was allowed to reach room 
temperature and stirred for 3 h. After cooling at 0 °C, the mixture 
was quenched with H2O and extracted with EtOAc. The organic 
layer was washed with brine, dried, and concentrated to give an oil 
(114 mg). Flash chromatography (8:2 hexane/EtOAc to 95:5 
EtOAc/MeOH) gave pentacycle 7 (31 mg, 33%), tetracycle 9 (6 
mg, 6%) and tetracycle 8 (14 mg, 19%). 
 
NaBH4 reduction of 7: NaBH4 (85 mg, 2.25 mmol) was slowly 
added (0 ºC) to a solution of 7 (120 mg, 0.45 mmol) in MeOH (10 
mL), and the suspension was stirred at room temperatur  for 1 h. 
The mixture was cooled at 0 °C, quenched with H2O, and extracted 
with CH2Cl2. The combined organic extracts were washed with 
brine, dried, and concentrated to give a yellow oil which was 
chromatographed (EtOAc) affording tetracycle 8 (108 mg, 90%). 
 
Data for 8: Light yellow oil. [α]22D = +36.5 (c =1.1, CHCl3). 
 1H 
NMR (400 MHz, CDCl3, COSY, HSQC, 25 ºC): δ = 1.21 (d, J = 
6.8 Hz, 3H, CH3), 1.30-1.39 (m, 1H, H-3), 1.40-1.52 (m, 1H, H-2), 
1.56-1.67 (m, 2H, H-1, H-3), 1.81-1.97 (m, 2H, H-1, H-2), 2.76 (dd, 
J = 15.0, 5.2 Hz, 1H, H-7), 2.96 (dd, J = 15.0, 3.1 Hz, 1H, H-7), 
3.14-3.24 (m, 1H, H-4), 3.49 (dd, J = 9.6, 8.4 Hz, 1H, CH2O), 
3.53-3.64 (m, 2H, H-12b, CH2O), 4.01 (br. d, J = 9.2 Hz, 1H, H-6), 
7.08 (td, J = 7.6, 1.2 Hz, 1H, H-10), 7.13 (td, J = 7.6, 1.2 Hz, 1H, 
H-9), 7.30 (d, J = 7.6 Hz, 1H, H-8), 7.47 (d, J = 7.1 Hz, 1H, H-11), 
7.80 (br. s, 1H, NH) ppm. NOESY 1D: positive NOE effect: 4-
H/6-H. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 20.0 (CH3), 23.2 
(C-7), 23.3 (C-1), 30.3 (C-2), 33.8 (C-3), 54.5 (C-4), 54.9 (C-12b), 
54.7 (C-6), 64.2 (CH2O), 107.1 (C-7a), 110.0 (C-8), 118.1 (C-11), 
119.3 (C-10), 121.2 (C-9), 127.7 (C-7b), 135.5 (C-12a), 135.9 (C-
11a) ppm. IR (NaCl): υ = 1453, 3257 cm-1. HRMS calcd. for 
C17H22N2O [M + H]
+: 271.1805; found: 271.1807. 
 
(6S,12bR)-6-(Hydroxymethyl)-12b-methyl-4-oxo-
1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine (9): TFA 
(0.9 M solution in CH2Cl2, 4 mL) was added to a solution of 
lactams 6 and epi-6 (100 mg, 0.35 mmol) in CH2Cl2 (2 mL), and 
the resulting mixture was stirred at room temperature for 20 h. The 
solvent was removed under reduced pressure, and the residue was 
dissolved in CH2Cl2 (6 mL). Then, KOH (150 mg, 2.7 mmol) was 
added, and the suspension was stirred at room temperatur  for 20 h. 
The resulting mixture was diluted with CH2Cl2 and washed twice 
with water. The organic layer was dried, filtered, and concentrated. 
Flash chromatography (8:2 hexane/EtOAc to EtOAc) gave 
tetracycle 9 (66 mg, 66%) and 12b-epi-9 (20 mg, 20%). 
 
Data for 9: Brown solid. [α]22D = +132.6 (c = 0.9, MeOH). 
1H 
NMR (CD3OD, 400 MHz, COSY, HSQC, 25 ºC): δ = 1.67 (s, 3H, 
CH3), 1.80 (td, J = 13.6, 4.6 Hz, 1H, H-1), 1.99-1.85 (m, 1H, H-2), 
2.25-2.05 (m, 1H, H-2), 2.35 (dt, J = 13.3, 3.2 Hz, 1H, H-1), 2.54 
(ddd, J = 18.5, 9.7, 9.0 Hz, 1H, H-3), 2.67 (dd, J = 18.5, 7.5 Hz, 
1H, H-3), 2.81 (dd, J = 15.8, 6.2 Hz, 1H, H-7), 3.04 (dd, J = 15.8, 
1.1 Hz, 1H, H-7), 3.54 (dd, J = 10.3, 6.1 Hz, 1H, CH2O), 3.62 (dd, 
J = 10.3, 8.9 Hz, 1H, CH2O), 5.45 (dd, J = 8.9, 6.1 Hz, 1H, H-6), 
7.03 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H, H-10), 7.11 (ddd, J = 8.2, 7.1, 
1.2 Hz, 1H, H-9), 7.33 (d, J = 8.1 Hz, 1H, H-8), 7.46 (d, J = 7.6 Hz, 
1H, H-11) ppm. 13C NMR (CD3OD, 100.6 MHz, 25 ºC): δ = 16.8 
(C-2), 21.9 (C-7), 27.6 (CH3), 31.4 (C-3), 38.2 (C-1), 50.7 (C-6), 
57.3 (C-12b), 63.8 (CH2O), 104.4 (C-7a), 111.9 (C-11), 118.9 (C-
8), 119.9 (C-10), 122.5 (C-9), 128.1 (C-7b), 137.9 (C-12a), 138.3 
(C-11a), 173.1 (CO) ppm. IR (NaCl): υ = 1609, 3268 cm-1. HRMS 
calcd. for C17H21N2O2 [M + H]
+: 285.1598; found: 285.1593.  
 
Data for 12b-epi-9: [α]22D = –168.8 (c = 1.0, MeOH). 
1H NMR 
(400 MHz, CD3OD, 25 ºC): δ = 1.74 (s, 3H, CH3), 1.75-1.84 (m, 
1H, H-2), 1.88-2.06 (m, 1H, H-1, H-2), 2.30-2.47 (m, 2H, H-1, H-
3), 2.52-2.62 (m, 1H, H-3), 2.84 (dd, J = 15.0, 3.1 Hz, 1H, H-7), 
3.07 (dd, J = 15.0, 8.7 Hz, 1H, H-7), 3.90-4.05 (m, 3H, H-6, 
CH2O), 7.02 (ddd, J = 8.0, 7.1, 1.2 Hz, 1H, H-10), 7.09 (ddd, J = 
8.0, 7.1, 1.2 Hz, 1H, H-9), 7.32 (d, J = 8.0 Hz, 1H, H-8), 7.44 (d, J 
= 7.8 Hz, 1H, H-11) ppm. 13C NMR (100.6 MHz, CD3OD, 25 ºC): 
δ = 17.6 (C-2), 23.7 (C-7), 27.2 (CH3), 33.9 (C-3), 36.5 (C-1), 59.4 
(C-6), 61.1 (C-12b), 64.3 (CH2O), 108.5 (C-7a), 112.1 (C-11), 
118.8 (C-8), 120.0 (C-10), 122.4 (C-9), 127.9 (C-7b), 137.9 (C-
12a), 140.1 (C-11a), 174.4 (CO) ppm. IR (NaCl): υ = 1613, 3268 
cm-1. HRMS calcd. for C17H21N2O2 [M + H]
+: 285.1598; found: 
285.1597.  
Data for 10: [α]22D = +160.9 (c =1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3, COSY, HSQC, 25 ºC): δ = 1.71 (s, 3H, CH3), 1.85 (td, J = 
13.0, 4.6 Hz, 1H, H-1), 1.90-1.99 (m, 1H, H-2), 2.03-2.21 (m, 1H, 
H-2), 2.27 (d, J = 13.0 Hz, 1H, H-1), 2.61 (dt, J = 18.5, 9.5 Hz, 1H, 
H-3), 2.74 (dd, J = 18.5, 7.5 Hz, 1H, H-3), 2.95 (dd, J = 16.0, 6.2 
Hz, 1H, H-7), 3.10 (dd, J = 16.0, 1.0 Hz, 1H, H-7), 3.55 (dd, J = 
10.5, 6.7 Hz, 1H, CH2Cl), 3.62 (dd, J = 10.5, 8.7 Hz, 1H, CH2Cl), 
5.72 (dd, J = 14.1, 6.8 Hz, 1H, H-6), 7.11-7.17 (m, 1H, H-10), 
7.17-7.23 (m, 1H, H-9), 7.36 (d, J = 8.0 Hz, 1H, H-8), 7.53 (d, J = 
7.8 Hz, 1H, H-11), 8.86 (br. s, 1H, NH) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 16.0 (C-2), 22.2 (C-7), 27.7 (CH3), 30.7 
(C-3), 37.7 (C-1), 45.5 (C-6), 48.7 (CH2Cl), 55.7 (C-12b), 104.1 
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(C-7a), 111.0 (C-11), 118.4 (C-8), 119.6 (C-10), 122.2 (C-9), 126.8 
(C-7b), 136.2 (C-12a), 136.6 (C-11a), 170.7 (CO) ppm. IR (NaCl): 
υ = 1397, 1611, 3268 cm-1. HRMS calcd. for C17H20ClN2O2 [M + 
H]+: 303.1259; found: 303.1251.  
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Crystal data and structure refinement for compound 9 
 
 
Identification code  Jb88 
Empirical formula  C17 H20 N2 O2 
Formula weight  284.35 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Tetragonal 
Space group  P 41 21 2 
Unit cell dimensions a = 10.0470(16) Å α = 90°. 
 b = 10.0470(18) Å β = 90°. 
 c = 28.929(6) Å γ  = 90°. 
Volume 2920.2(9) Å3 
Z 8 
Density (calculated) 1.294 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 1216 
Crystal size 0.27 x 0.27 x 0.12 mm3 
Theta range for data collection 2.15 to 24.98°. 
Index ranges -7<=h<=8, 0<=k<=11, 0<=l<=34 
Reflections collected 5841 
Independent reflections 2566  
Completeness to theta = 24.98° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2566 / 0 / 192 
Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.0428, wR2 = 0.0814 
R indices (all data) R1 = 0.0688, wR2 = 0.0893 
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Identification code  Jb89 
Empirical formula  C17 H20 N2 O2 
Formula weight  284.35 
Temperature  294(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 10.164(2) Å α = 90°. 
 b = 10.178(4) Å β = 90°. 
 c = 14.373(4) Å γ = 90°. 
Volume 1486.9(8) Å3 
Z 4 
Density (calculated) 1.270 Mg/m3 
Absorption coefficient 0.084 mm-1 
F(000) 608 
Crystal size 0.42 x 0.42 x 0.21 mm3 
Theta range for data collection 2.45 to 26.97°. 
Index ranges 0<=h<=12, 0<=k<=12, 0<=l<=18 
Reflections collected 1982 
Independent reflections 1848  
Completeness to theta = 26.97° 100.0 %  
Max. and min. transmission 0.9826 and 0.9656 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1848 / 0 / 192 
Goodness-of-fit on F2 1.029 
Final R indices [I>2sigma(I)] R1 = 0.0410, wR2 = 0.0852 
R indices (all data) R1 = 0.0662, wR2 = 0.0935 
Largest diff. peak and hole 0.133 and -0.139 e.Å-3 
 
 
